Efficacy of thalidomide in preventing delayed nausea and vomiting induced by highly emetogenic chemotherapy
Journal of Clinical Oncology Nov 05, 2017
Zhang L et al. -The efficacy and safety of thalidomide to prevent delayed nausea and vomiting in chemotherapy patients was determined.Thalidomide, together with palonosetron and dexamethasone, was effective in preventing highly emetogenic chemotherapy-induced delayed nausea and vomiting in chemotherapy patients.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
